The Dax started trading on Tuesday with slight gains. In the morning, the leading German index rose by 0.21 percent to 15,934.88 points. The MDax of medium-sized companies, however, fell by 0.47 percent to 26,271.79 points. The Eurozone index EuroStoxx 50 showed little change.
The Dax started trading on Tuesday with slight gains. In the morning, the leading German index rose by 0.21 percent to 15,934.88 points. The MDax of medium-sized companies, however, fell by 0.47 percent to 26,271.79 points. The Eurozone index EuroStoxx 50 showed little change.
As on the previous day, news from research led to price fluctuations. Disappointing study data for the cancer drug Pelabresib recently caused Morphosys’ share price to collapse by 28 percent. The biotech company’s securities have lost around half of their value in the past eight trading days. The day before, Bayer shares had plummeted due, among other things, to the termination of the clinical trial with the promising drug Asundexian.
New targets by 2026 gave the share price of the defense company and automotive supplier Rheinmetall an increase of up to 5.8 percent. At 295 euros, the shares marked a new record high. Rheinmetall wants to be more profitable by 2026 than previously expected.
Meanwhile, the financial investor Permira continues to cash in on the software provider Teamviewer. Through the placement of 13 million shares, the share falls from almost 21 percent to around 14 percent. The papers were offered for 13.90 euros each. Most recently they were trading eight percent lower and therefore below the placement price.
Source: Stern
